Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Association between urinary albumin creatinine ratio and cardiovascular disease

  • Yoo Jin Kim ,

    Contributed equally to this work with: Yoo Jin Kim, Sang Won Hwang

    Roles Investigation, Supervision, Writing – original draft, Writing – review & editing

    Affiliation Division of Nephrology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea

  • Sang Won Hwang ,

    Contributed equally to this work with: Yoo Jin Kim, Sang Won Hwang

    Roles Data curation, Formal analysis, Methodology, Resources, Software, Writing – original draft, Writing – review & editing

    Affiliation Artificial Intelligence Bigdata Medical Center, Yonsei University Wonju College of Medicine, Wonju, Korea

  • Taesic Lee,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

    Affiliations Department of Family Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea, The Study of Obesity and Metabolic Syndrome, KAFM, Korea

  • Jun Young Lee ,

    Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing (JYL); (YU)

    Affiliation Division of Nephrology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea

  • Young Uh

    Roles Conceptualization, Data curation, Funding acquisition, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing (JYL); (YU)

    Affiliation Department of Laboratory Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea



The association between microalbuminuria and cardiovascular disease (CVD) is accumulating in various patient populations. However, when stratified by sex, the relationship between microalbuminuria and CVD remains unclear.


We obtained data from the 2011–2014 and 2019–2020 Korea National Health and Nutrition Examination Survey (KNHANES). Microalbuminuria was measured based on spot urine albumin-creatinine ratio (UACR). The Framingham risk score (FRS) model was implemented to evaluate the CVD risk. Linear and logistic regression models were used to identify the associations of microalbuminuria status with cardiometabolic predictors and CVD status determined by the FRS score.


Among 19,340 representative Korean participants, the (UACR) in Korean women and men with history of CVD was higher than in those without history of CVD. Among patients without history of CVD, multivariate regression analysis showed that a high UACR was related to older age, lower high-density lipoprotein cholesterol level, higher total cholesterol level, higher systolic blood pressure, higher prevalence of current smoking, higher prevalence of diabetes, and higher anti-hypertensive medication use in both women and men. The UACR showed a positive linear correlation with the Framingham risk score in both women and men.


The presence of microalbuminuria was significantly associated with the cardiometabolic risk factors and the increased risk of CVD evaluated by FRS model in both women and men in a nationally representative sample of Korea.


Cumulative evidence indicates that albuminuria is associated with increased risk of cardiovascular diseases (CVDs) [1, 2]. The Heart Outcomes Prevention Evaluation (HOPE) study concluded that any degree of albuminuria (e.g., microalbuminuria) is a risk factor for cardiovascular (CV) events; particularly, a 0.4-mg/mmol increase in the albumin-creatinine ratio (ACR) was related to a 5.9% increased risk for CV events [1]. The Prevention of Renal and Vascular End Stage Disease (PREVEND) study, conducted among inhabitants of the city of Groningen (the Netherlands), reported that a 2-fold increase in albuminuria was associated with a 1.29 and 1.12-times increased risk for CV mortality and non-CV mortality, respectively [2]. The Prevention of Events with an ACE inhibitor (PEACE) trial showed that albuminuria, even at low levels within the normal range, is an independent predictor of CV mortality (hazard ratio per log ACR:1.74) [3]. This evidence comes from cohort studies not only from individuals at high risk of CVDs (patients with diabetes, hypertension, older adults, or stable coronary artery disease), but also from the general population [25]. Several studies have shown this association, even in patients with microalbuminuria [1, 6]. However, most studies pertain to sex-adjusted CV risk and no study has revealed sex-specific CV risk.

The Korea National Health and Nutrition Examination Survey (KNHANES) is a nationwide cohort in Korea that has collected urine albumin levels of participants since 2011. Initial studies that used the urinary albumin data from KNHAENS focused on identifying the risk factors related to albuminuria and/or microalbuminuria [7, 8]. Eventually, Korean nephrologists analyzed the 2011–2013 KNHANES, and reported clinical predictors related to albuminuria and/or chronic kidney disease (CKD) [9]. The accumulation of urine albumin data in KNHANES has diversified research topics. Body composition-related health problems have been studied as candidate association factors with albuminuria. Several studies using the KNHANES have reported the independent association between sarcopenia (also referred to as low skeletal muscle mass status) and albuminuria [10, 11]. A study analyzing urine albumin and body composition data in the KNHANES demonstrated that urine albumin level is related to bone mineral density of total hip in postmenopausal women [12].

Meanwhile, only a few studies analyzing KNHANES data have pinpointed the association between albuminuria and CVD [13]. Ahn et al. [13] obtained urine albumin data from the 2011–2013 KNHANES, and demonstrated that albuminuria could reflect CVD risk as measured by the Framingham risk score (FRS) [14]. However, this study only reported findings among postmenopausal women without diabetes [14]. Taken together, the current study aimed to evaluate the relationship between urine albumin-creatinine ratio (UACR) and CVD according to sex.


Ethics statement

All the participants enrolled in the KNHANES signed an informed consent form. The KNHANES data and their analyses in the present study were performed in compliance with the Declaration of Helsinki. The present study protocol was approved by the Institutional Review Board of Wonju Severance Christian Hospital (IRB No. CR321375).

Study population

This study analyzed data obtained from the 2011–2014 and 2019–2020 KNHANES. The KNHANES is conducted annually by the Division of Chronic Disease Surveillance of the Korea Centers for Disease Control and Prevention in the Ministry of Health and Welfare to assess and monitor the general and medical health and nutrition status in South Korea [15, 16]. The KNHANES includes three main components, a health interview, health examination, and nutrition survey. The KNHANES implements a complex, multi-stage probability sample design to obtain nationally representative data [15, 16]. The KNHANES is publicly available data ( Among 47,613 participants in the KNHANES, we excluded those aged under 40 years (n = 24,982), and those with missing information on demographics, lifestyle, medical, anthropometric, and laboratory variables (n = 3,291). After the exclusion, a total of 19,340 participants were analyzed.

Measurement of urine albumin and creatinine

The gold standard for measuring urine albumin excretion is 24-h urine collection. However, the National Kidney Foundation recommends the use of spot urine albumin-creatinine ratio to detect microalbuminuria, which is more convenient and accurate than 24-h urine collection. However, the cutoff value to diagnose microalbuminuria is different across different races and sex [17]. Therefore, we estimated sex-specific UACR and CV risk using data from the KNHANES.


Old age, diet (low intake of vegetables, fruits, and whole grain; and high intake of processed red meats, refined carbohydrates, and sweetened beverages), low or irregular physical activity, diabetes, and tobacco use are widely known risk factors for atherosclerotic CVD (ASCVD) or its related mortality [18]. Moreover, other factors, such as serum lipid profiles, air pollution, and genetic factors, are related to ASCVD [1921].

From representative models [22, 23], we determined seven predictors: age, total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), systolic blood pressure (SBP), antihypertensive medication (AHM), current smoking (CS), and diabetes as covariates.

Measurement of CVD risk score based on Framingham risk score

CVD risk score was measured using the FRS model [22]. The FRS model was established based on the Cox proportional hazards model which is widely used in the medical field [24]. The Cox model includes a linear unit and a non-linear unit (termed to survival function [22, 24]). The FRS includes an interaction term AHM×SBP, for which, the coefficient is 0.06106 (2.82263–2.76157) in women and 0.06578 (1.99881–1.93303) in men. The equation for calculating the FRS is as follows.

Linear predictor (LP)women = ln(age)×2.32888 + ln(TC) ×1.20904 + ln(HDL-C) ×(–0.70833) + ln(SBP)×2.76157 + ln(SBP)×AHM (0:no; 1: yes)×(2.82263–2.76157) + current smoking status × 0.52873 + diabetes×0.69154–26.1931

FRSwomen [22] = 1–0.95012exp(LPwomen)

FRSmen [22] = ln(age)×3.06117+ ln(TC) ×1.12370 + ln(HDL-C) ×(–0.93263) + ln(SBP)×1.93303 + ln(SBP)×AHM (0:no; 1: yes)×(1.99881–1.93303) + current smoking status × 0.65451 + diabetes×0.57367–23.9802

FRSmen [22] = 1–0.88936exp(Lpmen)


R language (version 4.0.1) [25] was implemented to reconstruct and preprocess the dataset and perform statistical analysis. Continuous variables, such as demographics (e.g., age) and laboratory values, were analyzed using ANOVAR. For categorical variables, the chi-square test was utilized. To evaluate the linear trends of categorical or continuous variables based on UACR tertile, we determined the median UACR levels of each tertile group as continuous variables when using the Chi-square test and one-way ANOVA.

To estimate the total population that the data would represent, we employed the sampling weights determined by the data constructors. After adopting the weight values, we analyzed the association between UACR and cardiometabolic risk factors included in the FRS equation. Multivariate linear or logistic regressions were performed using the following equation: cardiometabolic risk factors (dependent variable) ~ UACR (independent variable) + covariates. A p-value of < 0.05 was determined to be statistically significant.


The distribution of urine albumin (S1 Fig) among Korean women did not show abnormal distribution; instead, the distribution skewed left, indicating the existence of several outliers of urine albumin levels. After inclusion of cases with urine albumin less than 10 mg/dL, the patterns still did not show normal distribution; instead, they showed gamma or log-normal distributions. In contrast, urine creatinine levels in Korean women slightly skewed to the left, but generally followed a normal distribution. The distribution of UACR values in Korean men was similar to that of their urine albumin levels. These findings were consistent among Korean men (S2 Fig).

When comparing UACR levels according to the CVD status obtained from questionnaires, both mean and median values of UACR among Korean women were higher in the CVD group than in the non-CVD group (median [non-CVD/CVD groups] = 5.99/8 mg/g; mean = 20.8/60.8 mg/g, Fig 1A). However, in the non-CVD group, many outliers had extremely high UACRs because most participants were in the non-CVD group (Fig 1A). These results were also exhibited among Korean men because the prevalence of CVD was low in both Korean men and women (Fig 1A). Among the self-reported responses, we found that the UACR was high in CVD status; therefore, as the next step, we evaluated the association between UACR, and CVD status measured by FRS score after excluding CVD patients.

Fig 1.

UACRs according to CVD status in Korean women (A) and men (B). Left side boxplots (grey and brown colored boxes) indicate median-based summary statistics; specifically, the middle, upper, and lower lines describe median, 75, and 25 percentile values, respectively. Right side boxplots indicate mean-based summary statistics, in which the middle, upper, and lower lines illustrate mean, one standard deviation values, respectively.

Different general characteristics were shown among Korean women according to increasing UACR: older age, higher SBP, higher TC, lower HDL-C, greater AHM use, higher prevalence in diabetes, and higher levels of FRS. For Korean men, most risk factors, except for the serum levels of TC, exhibited similar bio-signatures compared to those of Korean women (Table 1). However, as the UACR increased from tertile 1 to tertile 3, the number of current smokers did not show any significant difference between men and women. Note that all participants analyzed in Table 1 were not diagnosed with CVD.

Table 1. Sex-specific characteristics according to UACR tertile.

We analyzed the association of the UACR with seven risk factors used in the calculation of FRS based on univariate analysis. In both Korean women and men, the following robust and significant signatures were associated with increase in the UACR: older age, lower TC, lower HDL-C, higher SBP, higher ratio of hypertensive medication, and higher prevalence of diabetes (Fig 2).

Fig 2.

Relationship between UACR and cardiometabolic risk factors in Korean women (A) and men (B). Beta values were measured by linear regression after setting continuous variables, including age, TC, HDL-C, and SBP as dependent variables and UACR subgroups as independent variables. In case of features exhibiting binomial distribution, such as AHM use, smoking, and diabetes, the ratio of presence of disease or status was set as the dependent variable in the linear regression for the calculation of the Beta value. Abbreviations: UACR, urinary albumin-creatinine ratio; Beta, beta-coefficient; AHM, anti-hypertensive medication; HDL-C. high-density lipoprotein-cholesterol; SBP, systolic blood pressure; TC, total cholesterol.

The FRS included seven cardiometabolic predictors, including age, TC, HDL-C SBP, AHM, smoking, and diabetes. Among six features, four were continuous variables set as dependent variables in each model using multivariate linear regression. The UACR was the independent variable, and the other six variables were covariates (Fig 3). In case of dichotomous variables, including AHM, smoking, and diabetes, logistic regression was used to evaluate their association with UACR after adjusting for the other remaining six predictors (Fig 3). As a result, in both Korean women and men, the high levels of UACR were related to older age, higher TC, lower HDL-C, higher SBP, greater smoking levels, greater AHM use, and diabetes were related to FRS (Fig 3).

Fig 3.

Relationship between albuminuria and cardiometabolic risk factors in Korean women (A) and men (B). Top four graphs (i.e., age, TC, HDL-C, SBP) were obtained by multivariate linear regression after setting the four predictors arranged separately as dependent variables. UACR was determined as the independent variable, and other remnant six predictors as covariates. The lower three graphs (i.e., AHM, smoking, diabetes) were obtained by multivariate logistic regression set to the same conditions as the multivariate linear regression. All x-axes indicate beta-coefficients obtained from the multivariate linear or logistic regressions. UACR levels were log-transformed for the associational analyses. Abbreviations: TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; SBP, systolic blood pressure; HTN Med, hypertension medication; DM, diabetes mellitus.

We compared the relationship between UACR and the combined effect of seven cardiometabolic predictors, in the form of an equation, referred to as the FRS (Fig 4). In both women and men, as UACR increased, the FRS exhibited monotonic elevated patterns. Moreover, all the increasing characteristics showed exponential distributions, indicating that the albuminuria groups (Q16 –Q20 in Fig 4) were directly proportional to extremely high risk of CVD.

Fig 4.

Relationship between albuminuria and FRS in Korean women (A) and men (B). Urine albumin-to-creatine ratio was categorized into 20 groups (x-axes) based on ascending order. FRS was calculated based on the equation provided by a study [22]. Abbreviation: FRS, Framingham risk score.


Our study showed that both Korean women and men with CVD history had higher UACR level than those with no previous history of CVD. In particular, for those without CVD history, multivariate adjusted analysis showed that higher UACR was associated with CV risk factors such as older age, higher TC, lower HDL, higher SBP, higher proportion of HTN, higher proportion of current smoking, and higher proportion of diabetes in both Korean women and men. In both women and men without CVD history, UACR showed positive correlation with FRS. In correlation analyses between UACR and individual cardiometabolic risk factors, several non-linear correlations were shown: age, TC, HDL-C, SBP, smoking status in Korean women and men (Fig 2). Moreover, gender-specific associational findings could be observed (Fig 2). For example, in Korean men, UACR levels were negatively related to HDL-C levels (beta-coefficients: -0.1834; p-value < 0.001), besides, in Korean women, this trend slightly were diluted (beta-coefficient: -0.0738; p-value: 0.0011).

The HOPE and PEACE studies showed that albuminuria is associated with a higher risk of CVD incidence and mortality among high-risk patients with CVD [1, 3]. Moreover, albuminuria was associated with the risk of CVD among healthy individuals in the general population, without history of CVD [5, 26, 27]. The Multi-Ethnic Study of Atherosclerosis (MESA) study showed that UACR was associated with an 11% increase in the risk of CVD events [5]. The Framingham cohort study reported that without CVD, low level of UACR predicted the development of CVD among normotensive and nondiabetic individuals [28]. The Strong Heart Study also showed that a lower UACR than the normal value predicted CVD [27]. The Prevention of Renal and Vascular End Stage Disease Intervention Trial (PREVEND IT) study showed that the FRS is correlated with microalbuminuria [29].

The risk of CVD differs according to sex. Our results showed that the prevalence of smoking was more common among men than women, and the prevalence of obesity was higher among women than men. Moreover, women tended to have better levels of cholesterol and blood pressure. These differences have been attributed to the differences in lifestyle, health awareness, and sex hormones (such as estrogen). Recently, this difference has been decreasing; however, the difference in cholesterol and body mass index among the different sexes remains significant [30]. Because there are still differences in the control of high blood pressure, diabetes, and hyperlipidemia among different sexes, it is necessary to stratify and analyze microalbuminuria as a risk factor for CVD by sex. Our results showed that microalbuminuria could be considered an important predictor of CVD regardless of sex.

The precise pathophysiological mechanism of microalbuminuria as a CV risk factor remains unknown. The association between microalbuminuria and CVD is explained by endothelial dysfunction or chronic low-grade inflammation. Endothelial dysfunction could increase glomerular pressure and glomerular barrier permeability which increases endothelial permeability. Increased microalbuminuria could be a marker of generalized endothelial dysfunction which could predispose to an atherogenic lipoprotein accumulation in the subendothelial cell space [31, 32]. Microalbuminuria is also associated with chronic low-grade inflammation which could be both cause and consequence of endothelial dysfunction. Furthermore, endothelial dysfunction and low-grade inflammation can not only lead to atherothrombosis but can also be independently associated as a risk for CVD [32, 33].

Diabetic patients have an increased risk of microalbuminuria and 20–30% of patients with diagnosed diabetes have been found to have microalbuminuria [34]. Those patients have abnormal insulin resistance and increased serum glucose level that makes serum insulin level increase. Insulin stimulates store-operated Ca entry via Orai-1 channel in podocytes that makes actin remodeling and transepithelial albumin leakage resulting in microalbuminuria [35]. Recently over 8 years follow up study from Korean Genome and Epidemiology Study (KOGES) showed that microalbuminuria could be used as an early marker of progression to diabetes even in the non-prediabetic population [36]. Through microalbuminuria we could predict abnormal insulin resistance and diabetes, which were major risk factors for cardiovascular disease [37, 38].

This study has several limitations. First, this was a cross-sectional designed study, therefore, a causal relationship between the exposure (i.e., UACR) and outcome (i.e., CVD status) could not be established, but only association between them could only be identified. To establish causation between UACR and CVD status, a longitudinal study design, intervention study design, or study using mendelian randomization analysis [39] is required. Second, we implemented the FRS to categorize subjects into binomial groups, including high- and low-risk CVD groups. Two reasons not to use the real CVD status obtained from a questionnaire for individuals’ current condition or diagnosis with CVD: the prevalence of CVD in KNHANES is extremely low, therefore, could yield the biased results; the real CVD status only reflects a subject’s current condition, besides, the FRS could predict their future risk of the incidence of CVD. Third, we could not consider the use of medications such as angiotensin-converting enzyme inhibitors or angiotensin receptor blockers which may reduce the degree of microalbuminuria. Fourth, we used a single urine spot sample to assess the UACR rather than the 24-hour urine collection or multiple samples. Nevertheless, we investigated the correlation between microalbuminuria and CVD in a single representative group by using nationally notarized data.

In conclusion, our study showed that UACR level was associated with FRS in both women and men with no previous history of CVD. In addition to FRS, measuring UACR is a cost-effective tool for predicting and preventing CVD in both sexes.

Supporting information

S1 Fig.

Distribution of urine albumin (upper two figures), urinary creatinine (middle figure), and urinary albumin creatinine ratio (lower two figures) in Korean women.


S2 Fig.

Distribution of urine albumin (upper two figures), urinary creatinine (middle figure), and urinary albumin creatinine ratio (lower two figures) in Korean men.



We special thank Pharmicell for technical support.


  1. 1. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Jama. 2001;286(4):421–6. pmid:11466120.
  2. 2. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106(14):1777–82. pmid:12356629.
  3. 3. Solomon SD, Lin J, Solomon CG, Jablonski KA, Rice MM, Steffes M, et al. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation. 2007;116(23):2687–93. Epub 20071119. pmid:18025537.
  4. 4. Cirillo M, Laurenzi M, Panarelli P, Mancini M, Zanchetti A, De Santo NG. Relation of urinary albumin excretion to coronary heart disease and low renal function: role of blood pressure. Kidney Int. 2004;65(6):2290–7. pmid:15149342.
  5. 5. Carter CE, Katz R, Kramer H, de Boer IH, Kestenbaum BR, Peralta CA, et al. Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2013;62(4):722–9. Epub 20130702. pmid:23830183; PubMed Central PMCID: PMC3783582.
  6. 6. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984;310(6):356–60. pmid:6690964.
  7. 7. Won JC, Lee YJ, Kim JM, Han SY, Noh JH, Ko KS, et al. Prevalence of and factors associated with albuminuria in the Korean adult population: the 2011 Korea National Health and Nutrition Examination Survey. PLoS One. 2013;8(12):e83273. Epub 20131227. pmid:24386169; PubMed Central PMCID: PMC3873941.
  8. 8. Kim CH, Kim KJ, Kim BY, Jung CH, Mok JO, Kang SK, et al. Prediabetes is not independently associated with microalbuminuria in Korean general population: the Korea National Health and Nutrition Examination Survey 2011–2012 (KNHANES V-2,3). Diabetes Res Clin Pract. 2014;106(2):e18–21. Epub 20140922. pmid:25271114.
  9. 9. Park JI, Baek H, Jung HH. Prevalence of chronic kidney disease in Korea: the Korean National Health and Nutritional Examination Survey 2011–2013. J Korean Med Sci. 2016;31(6):915–23. Epub 20160422. pmid:27247501; PubMed Central PMCID: PMC4853671.
  10. 10. Han E, Lee YH, Kim G, Kim SR, Lee BW, Kang ES, et al. Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008–2011. Metabolism. 2016;65(10):1531–40. Epub 20160708. pmid:27621188.
  11. 11. Yoon HE, Nam Y, Kang E, Hwang HS, Shin SJ, Hong YS, et al. Gender-Specific associations between low skeletal muscle mass and albuminuria in the middle-aged and elderly population. Int J Med Sci. 2017;14(11):1054–64. Epub 20170903. pmid:29104458; PubMed Central PMCID: PMC5666535.
  12. 12. Yu TY, Kim HY, Lee JM, Lee DH, Cho CG. Association between bone mineral density and albuminuria: cross-sectional analysis of data from the 2011 Korea National Health and Nutrition Examination Survey V-2. Endocrinol Metab (Seoul). 2018;33(2):211–8. Epub 20180504. pmid:29766678; PubMed Central PMCID: PMC6021310.
  13. 13. Ahn HJ, Moon DS, Kang DY, Lee JI, Kim DY, Kim JH, et al. Urinary albumin excretion reflects cardiovascular risk in postmenopausal women without diabetes: the 2011 to 2013 Korean National Health and Nutrition Examination Survey. Endocrinol Metab. 2016;31(4):537–46. pmid:27834079.
  14. 14. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421. pmid:12485966.
  15. 15. Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43(1):69–77. pmid:24585853; PubMed Central PMCID: PMC3937975.
  16. 16. Kim Y. The Korea National Health and Nutrition Examination Survey (KNHANES): current status and challenges. Epidemiol Health. 2014;36:e2014002. Epub 20140430. pmid:24839580; PubMed Central PMCID: PMC4017741.
  17. 17. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002;13(4):1034–9. Epub 2002/03/26. pmid:11912263.
  18. 18. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;140(11):e596–e646. Epub 20190317. pmid:30879355; PubMed Central PMCID: PMC7734661.
  19. 19. Cholesterol Treatment Trialists C, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet (London, England). 2012;380(9841):581–90. Epub 2012/05/17. pmid:22607822.
  20. 20. Franklin BA, Brook R, Arden Pope C, 3rd. Air pollution and cardiovascular disease. Curr Probl Cardiol. 2015;40(5):207–38. Epub 20150103. pmid:25882781.
  21. 21. Lee T, Lee H, The Alzheimer’s Disease Neuroimaging I. Identification of disease-related genes that are common between Alzheimer’s and cardiovascular disease using blood genome-wide transcriptome analysis. Biomedicines. 2021;9(11):1525. pmid:34829754.
  22. 22. D’Agostino RB Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53. Epub 2008/01/24. pmid:18212285.
  23. 23. Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49–73. Epub 2013/11/14. pmid:24222018.
  24. 24. Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society Series B (Methodological). 1972;34(2):187–220.
  25. 25. R Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing; 2019. Available from:
  26. 26. Romundstad S, Holmen J, Kvenild K, Hallan H, Ellekjaer H. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway. Am J Kidney Dis. 2003;42(3):466–73. pmid:12955674.
  27. 27. Xu J, Knowler WC, Devereux RB, Yeh J, Umans JG, Begum M, et al. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. Am J Kidney Dis. 2007;49(2):208–16. pmid:17261423.
  28. 28. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112(7):969–75. Epub 20050808. pmid:16087792.
  29. 29. Asselbergs FW, Hillege HL, van Gilst WH. Framingham score and microalbuminuria: combined future targets for primary prevention? Kidney Int Suppl. 2004;(92):S111–4. pmid:15485402.
  30. 30. Peters SAE, Muntner P, Woodward M. Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016. Circulation. 2019;139(8):1025–35. pmid:30779652.
  31. 31. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32(4):219–26. pmid:2668076.
  32. 32. Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Lond). 1995;88(6):629–33. pmid:7634745.
  33. 33. Nosadini R, Velussi M, Brocco E, Abaterusso C, Piarulli F, Morgia G, et al. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms. Diabetes. 2005;54(1):228–33. pmid:15616033.
  34. 34. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39(3):445–59. pmid:11877563.
  35. 35. Kim J-H, Hwang K-H, Dang BTN, Eom M, Kong ID, Gwack Y, et al. Insulin-activated store-operated Ca2+ entry via Orai1 induces podocyte actin remodeling and causes proteinuria. Nat Commun. 2021;12(1):6537. pmid:34764278
  36. 36. Jung D-H, Byun Y-S, Kwon Y-J, Kim G-S. Microalbuminuria as a simple predictor of incident diabetes over 8 years in the Korean Genome and Epidemiology Study (KoGES). Sci Rep. 2017;7(1):15445. pmid:29133894
  37. 37. Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(2):1449–55. pmid:31336505
  38. 38. Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2020;26(2_suppl):25–32. pmid:31722562
  39. 39. Liu X, Tong X, Zou Y, Lin X, Zhao H, Tian L, et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome. Nature Genetics. 2022;54(1):52–61. pmid:34980918